Hetero has launched its generic semaglutide portfolio in overseas markets even as it is awaiting regulatory approvals in India. The launch represents the beginning of a strategic, multi-year global ...

Two-time cancer survivor Sherman McDaniel may be in fragile health, but she is sticking to her vow: “I’m not going anywhere until Generic Theater has a permanent home. Until then, I will not die.” ...

MUMBAI, (IANS) – Pharma major Lupin Limited has said that it has launched Mirabegron extended-release tablets, 25 mg, in the US market, after having received approval from the Food and Drug ...

TORONTO - Anne Welch worked a physically demanding job at her local SPCA — lifting pets, cleaning kennels and walking dogs — until she retired at age 71. With the loss of that physical activity, ...

Did our AI summary help? Hetero has begun exporting generic versions of semaglutide, accelerating competition in the global market for diabetes and obesity medicines as demand for GLP‑1 therapies ...

Mumbai: Last week, the central government announced that it is collaborating with states to promote the use of generic medicines in government hospitals. As per regulations set by the National Medical ...

Generic dapagliflozin is indicated for adults with type 2 diabetes and to reduce heart failure hospitalization risk in adults with T2D and established cardiovascular disease. The Food and Drug ...

LOWERING DRUG COSTS — Bipartisan lawmakers have revived efforts to require Medicare to cover generic drugs — and at least two biosimilars — with patients paying lower costs than for brand-name drugs, ...

Dapagliflozin tablets are indicated to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes. Clobetasol propionate foam is indicated for the treatment of moderate to ...

Novo Nordisk (NVO) (NONOF) has once again reduced the prices of its GLP-1 medicine, semaglutide, in India as the company grapples with cheaper copycat versions of the popular GLP-1 therapy marketed as ...

Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. REUTERS/Hollie Adams March 31 (Reuters) - Novo Nordisk on Tuesday cut the prices of its ...